Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Aggiunta di Nivolumab al trattamento abituale per le persone con cancro avanzato dello stomaco o dell'esofago, lo studio PARAMMUNE

29 ottobre 2026 aggiornato da: National Cancer Institute (NCI)

Randomized Phase II/III Trial of 2nd Line Nivolumab + Paclitaxel + Ramucirumab Versus Paclitaxel + Ramucirumab in Patients With PD-L1 CPS >/= 1 Advanced Gastric and Esophageal Adenocarcinoma (PARAMUNE)

This phase II/III trial compares the addition of nivolumab to the usual treatment of paclitaxel and ramucirumab to paclitaxel and ramucirumab alone in treating patients with gastric or esophageal adenocarcinoma that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). A monoclonal antibody is a type of protein that can bind to certain targets in the body, such as molecules that cause the body to make an immune response (antigens). Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Ramucirumab is a monoclonal antibody that may prevent the growth of new blood vessels that tumors need to grow. Paclitaxel is in a class of medications called antimicrotubule agents. It stops cancer cells from growing and dividing and may kill them. Adding nivolumab to ramucirumab and paclitaxel may work better to treat patients with advanced stomach or esophageal cancer.

Panoramica dello studio

Stato

Reclutamento

Condizioni

Intervento / Trattamento

Descrizione dettagliata

PRIMARY OBJECTIVES:

I. To assess whether progression-free survival (PFS) is sufficiently improved in participants randomized to nivolumab + paclitaxel + ramucirumab compared to those randomized to paclitaxel + ramucirumab to warrant a phase III study with overall survival (OS) as the primary endpoint. (Phase II) II. To compare OS in participants randomized to nivolumab + paclitaxel + ramucirumab versus those randomized to paclitaxel + ramucirumab. (Phase III)

SECONDARY OBJECTIVES:

I. To compare PFS between those randomized to nivolumab + paclitaxel + ramucirumab versus those randomized to paclitaxel + ramucirumab. (Phase III) II. To compare OS between participants randomized to nivolumab + paclitaxel + ramucirumab compared to those randomized to paclitaxel + ramucirumab in the event that the trial is completed before the phase III portion.

III. To compare the overall response rate (ORR, including confirmed and unconfirmed, complete, and partial response, according to Response Evaluation Criteria in Solid Tumors [RECIST 1.1] criteria) between those randomized to nivolumab + paclitaxel + ramucirumab compared to those randomized to paclitaxel + ramucirumab among participants with measurable disease.

IV. To compare the overall disease control rate (DCR = ORR + stable disease) between those randomized to nivolumab + paclitaxel + ramucirumab compared to those randomized to paclitaxel + ramucirumab among participants with measurable disease.

V. To evaluate the safety and tolerability of each treatment regimen. VI. To compare health-related quality of life (QOL) by treatment arm at 8 weeks after randomization, measured using the Functional Assessment of Cancer Therapy - Gastric (FACT-Ga) Trial Outcome Index (TOI).

VII. To compare health-related QOL between treatment arms at 8 weeks after randomization using the FACT-Ga total score.

VIII. To compare longitudinal changes in health-related QOL between treatment arms using FACT-Ga TOI up to 24 weeks after randomization.

IX. To compare patient-reported symptoms using selected Patient-Reported Outcomes-Common Terminology Criteria for Adverse Events (PRO-CTCAE) items including gastrointestinal as well as constitutional symptoms of fatigue, anorexia, and weight loss between treatment arms.

OUTLINE: Patients are randomized to 1 of 2 arms.

ARM 1: Patients receive nivolumab intravenously (IV) over 30 minutes on day 1 of each cycle, ramucirumab IV over 30-60 minutes on days 1 and 15 of each cycle, and paclitaxel IV over 60 minutes on days 1, 8 and 15 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients undergo computed tomography (CT) scan and magnetic resonance imaging (MRI) throughout the study. Patients may also optionally undergo blood sample collection on study.

ARM 2: Patients receive ramucirumab IV over 30-60 minutes on days 1 and 15 of each cycle and paclitaxel IV over 60 minutes on days 1, 8 and 15 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients undergo CT scan and MRI throughout the study. Patients may also optionally undergo blood sample collection on study.

After completion of study treatment, patients are followed up at 30, 60, 90 days and then every 6 months for up to 3 years.

Tipo di studio

Interventistico

Iscrizione (Stimato)

224

Fase

  • Fase 2
  • Fase 3

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

  • Stati Uniti
    • Arkansas
      • Little Rock, Arkansas, Stati Uniti, 72205
        • Reclutamento
        • University of Arkansas for Medical Sciences
        • Investigatore principale:
          • Rangaswamy Govindarajan
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 501-686-8274
      • Little Rock, Arkansas, Stati Uniti, 72205
        • Reclutamento
        • Baptist Health Medical Center - Little Rock
        • Investigatore principale:
          • Rangaswamy Govindarajan
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 501-202-4715
    • California
      • Anaheim, California, Stati Uniti, 92806
        • Reclutamento
        • Kaiser Permanente-Anaheim
        • Contatto:
        • Investigatore principale:
          • Gary L. Buchschacher
      • Baldwin Park, California, Stati Uniti, 91706
        • Reclutamento
        • Kaiser Permanente-Baldwin Park
        • Contatto:
        • Investigatore principale:
          • Gary L. Buchschacher
      • Bellflower, California, Stati Uniti, 90706
        • Reclutamento
        • Kaiser Permanente-Bellflower
        • Contatto:
        • Investigatore principale:
          • Gary L. Buchschacher
      • Beverly Hills, California, Stati Uniti, 90211
      • Dublin, California, Stati Uniti, 94568
        • Reclutamento
        • Kaiser Permanente Dublin
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 877-642-4691
        • Investigatore principale:
          • Tilak K. Sundaresan
      • Fontana, California, Stati Uniti, 92335
        • Reclutamento
        • Kaiser Permanente-Fontana
        • Contatto:
        • Investigatore principale:
          • Gary L. Buchschacher
      • Fremont, California, Stati Uniti, 94538
        • Reclutamento
        • Kaiser Permanente-Fremont
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 877-642-4691
          • Email: Kpoct@kp.org
        • Investigatore principale:
          • Tilak K. Sundaresan
      • Fresno, California, Stati Uniti, 93720
        • Reclutamento
        • Kaiser Permanente-Fresno
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 877-642-4691
          • Email: Kpoct@kp.org
        • Investigatore principale:
          • Tilak K. Sundaresan
      • Fresno, California, Stati Uniti, 93720
        • Reclutamento
        • Kaiser Permanente Fresno Orchard Plaza
        • Investigatore principale:
          • Tilak K. Sundaresan
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 833-574-2273
      • Harbor City, California, Stati Uniti, 90710
        • Reclutamento
        • Kaiser Permanente South Bay
        • Contatto:
        • Investigatore principale:
          • Gary L. Buchschacher
      • Irvine, California, Stati Uniti, 92618
        • Reclutamento
        • Kaiser Permanente-Irvine
        • Contatto:
        • Investigatore principale:
          • Gary L. Buchschacher
      • La Jolla, California, Stati Uniti, 92093
        • Reclutamento
        • UC San Diego Moores Cancer Center
        • Investigatore principale:
          • Aaron Miller
        • Contatto:
      • Los Angeles, California, Stati Uniti, 90048
        • Reclutamento
        • Cedars-Sinai Medical Center
        • Investigatore principale:
          • Jun Gong
        • Contatto:
      • Los Angeles, California, Stati Uniti, 90027
        • Reclutamento
        • Kaiser Permanente Los Angeles Medical Center
        • Contatto:
        • Investigatore principale:
          • Gary L. Buchschacher
      • Los Angeles, California, Stati Uniti, 90034
        • Reclutamento
        • Kaiser Permanente West Los Angeles
        • Contatto:
        • Investigatore principale:
          • Gary L. Buchschacher
      • Los Angeles, California, Stati Uniti, 90033
        • Reclutamento
        • USC / Norris Comprehensive Cancer Center
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 323-865-0451
        • Investigatore principale:
          • Syma Iqbal
      • Los Angeles, California, Stati Uniti, 90020
        • Reclutamento
        • Keck Medicine of USC Koreatown
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 213-388-0908
        • Investigatore principale:
          • Syma Iqbal
      • Los Angeles, California, Stati Uniti, 90033
        • Reclutamento
        • Los Angeles General Medical Center
        • Investigatore principale:
          • Syma Iqbal
        • Contatto:
      • Modesto, California, Stati Uniti, 95356
        • Reclutamento
        • Kaiser Permanente-Modesto
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 877-642-4691
          • Email: Kpoct@kp.org
        • Investigatore principale:
          • Tilak K. Sundaresan
      • Modesto, California, Stati Uniti, 95356
        • Reclutamento
        • Kaiser Permanente- Modesto MOB II
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 877-642-4691
        • Investigatore principale:
          • Tilak K. Sundaresan
      • Newport Beach, California, Stati Uniti, 92663
        • Reclutamento
        • USC Norris Oncology/Hematology-Newport Beach
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 323-865-0451
        • Investigatore principale:
          • Syma Iqbal
      • Oakland, California, Stati Uniti, 94611
        • Reclutamento
        • Kaiser Permanente-Oakland
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 877-642-4691
          • Email: Kpoct@kp.org
        • Investigatore principale:
          • Tilak K. Sundaresan
      • Ontario, California, Stati Uniti, 91761
        • Reclutamento
        • Kaiser Permanente-Ontario
        • Contatto:
        • Investigatore principale:
          • Gary L. Buchschacher
      • Panorama City, California, Stati Uniti, 91402
        • Reclutamento
        • Kaiser Permanente - Panorama City
        • Contatto:
        • Investigatore principale:
          • Gary L. Buchschacher
      • Riverside, California, Stati Uniti, 92505
        • Reclutamento
        • Kaiser Permanente-Riverside
        • Contatto:
        • Investigatore principale:
          • Gary L. Buchschacher
      • Roseville, California, Stati Uniti, 95661
        • Reclutamento
        • Kaiser Permanente-Roseville
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 877-642-4691
          • Email: Kpoct@kp.org
        • Investigatore principale:
          • Tilak K. Sundaresan
      • Sacramento, California, Stati Uniti, 95814
        • Reclutamento
        • Kaiser Permanente Downtown Commons
        • Investigatore principale:
          • Tilak K. Sundaresan
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 877-642-4691
          • Email: kpoct@kp.org
      • Sacramento, California, Stati Uniti, 95823
        • Reclutamento
        • Kaiser Permanente-South Sacramento
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 877-642-4691
          • Email: Kpoct@kp.org
        • Investigatore principale:
          • Tilak K. Sundaresan
      • Sacramento, California, Stati Uniti, 95817
        • Attivo, non reclutante
        • University of California Davis Comprehensive Cancer Center
      • San Diego, California, Stati Uniti, 92120
        • Reclutamento
        • Kaiser Permanente-San Diego Zion
        • Contatto:
        • Investigatore principale:
          • Gary L. Buchschacher
      • San Francisco, California, Stati Uniti, 94115
        • Reclutamento
        • Kaiser Permanente-San Francisco
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 877-642-4691
          • Email: Kpoct@kp.org
        • Investigatore principale:
          • Tilak K. Sundaresan
      • San Jose, California, Stati Uniti, 95119
        • Reclutamento
        • Kaiser Permanente-Santa Teresa-San Jose
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 877-642-4691
          • Email: Kpoct@kp.org
        • Investigatore principale:
          • Tilak K. Sundaresan
      • San Leandro, California, Stati Uniti, 94577
        • Reclutamento
        • Kaiser Permanente San Leandro
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 877-642-4691
          • Email: Kpoct@kp.org
        • Investigatore principale:
          • Tilak K. Sundaresan
      • San Marcos, California, Stati Uniti, 92078
        • Reclutamento
        • Kaiser Permanente-San Marcos
        • Contatto:
        • Investigatore principale:
          • Gary L. Buchschacher
      • San Rafael, California, Stati Uniti, 94903
        • Reclutamento
        • Kaiser San Rafael-Gallinas
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 877-642-4691
          • Email: Kpoct@kp.org
        • Investigatore principale:
          • Tilak K. Sundaresan
      • Santa Clara, California, Stati Uniti, 95051
        • Reclutamento
        • Kaiser Permanente Medical Center - Santa Clara
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 877-642-4691
          • Email: Kpoct@kp.org
        • Investigatore principale:
          • Tilak K. Sundaresan
      • Santa Rosa, California, Stati Uniti, 95403
        • Reclutamento
        • Kaiser Permanente-Santa Rosa
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 877-642-4691
          • Email: Kpoct@kp.org
        • Investigatore principale:
          • Tilak K. Sundaresan
      • South San Francisco, California, Stati Uniti, 94080
        • Reclutamento
        • Kaiser Permanente-South San Francisco
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 877-642-4691
          • Email: Kpoct@kp.org
        • Investigatore principale:
          • Tilak K. Sundaresan
      • Vallejo, California, Stati Uniti, 94589
        • Reclutamento
        • Kaiser Permanente-Vallejo
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 877-642-4691
          • Email: Kpoct@kp.org
        • Investigatore principale:
          • Tilak K. Sundaresan
      • Walnut Creek, California, Stati Uniti, 94596
        • Reclutamento
        • Kaiser Permanente-Walnut Creek
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 877-642-4691
          • Email: Kpoct@kp.org
        • Investigatore principale:
          • Tilak K. Sundaresan
      • Woodland Hills, California, Stati Uniti, 91367
        • Reclutamento
        • Kaiser Permanente-Woodland Hills
        • Contatto:
        • Investigatore principale:
          • Gary L. Buchschacher
    • Colorado
      • Colorado Springs, Colorado, Stati Uniti, 80909
        • Reclutamento
        • UCHealth Memorial Hospital Central
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 719-365-2406
        • Investigatore principale:
          • Shin Yin Lee
      • Colorado Springs, Colorado, Stati Uniti, 80920
        • Reclutamento
        • Memorial Hospital North
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 719-364-6700
        • Investigatore principale:
          • Shin Yin Lee
      • Fort Collins, Colorado, Stati Uniti, 80524
        • Reclutamento
        • Poudre Valley Hospital
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 970-297-6150
        • Investigatore principale:
          • Shin Yin Lee
      • Fort Collins, Colorado, Stati Uniti, 80528
        • Reclutamento
        • Cancer Care and Hematology-Fort Collins
        • Contatto:
        • Investigatore principale:
          • Shin Yin Lee
      • Greeley, Colorado, Stati Uniti, 80631
        • Reclutamento
        • UCHealth Greeley Hospital
        • Contatto:
        • Investigatore principale:
          • Shin Yin Lee
      • Loveland, Colorado, Stati Uniti, 80538
        • Reclutamento
        • Medical Center of the Rockies
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 970-203-7083
        • Investigatore principale:
          • Shin Yin Lee
    • Connecticut
      • Derby, Connecticut, Stati Uniti, 06418
        • Reclutamento
        • Smilow Cancer Hospital-Derby Care Center
        • Contatto:
        • Investigatore principale:
          • Yifei Zhang
      • Fairfield, Connecticut, Stati Uniti, 06824
        • Reclutamento
        • Smilow Cancer Hospital Care Center-Fairfield
        • Contatto:
        • Investigatore principale:
          • Yifei Zhang
      • Glastonbury, Connecticut, Stati Uniti, 06033
        • Reclutamento
        • Smilow Cancer Hospital Care Center at Glastonbury
        • Contatto:
        • Investigatore principale:
          • Yifei Zhang
      • Greenwich, Connecticut, Stati Uniti, 06830
        • Reclutamento
        • Smilow Cancer Hospital Care Center at Greenwich
        • Contatto:
        • Investigatore principale:
          • Yifei Zhang
      • Guilford, Connecticut, Stati Uniti, 06437
        • Reclutamento
        • Smilow Cancer Hospital Care Center - Guilford
        • Contatto:
        • Investigatore principale:
          • Yifei Zhang
      • Hartford, Connecticut, Stati Uniti, 06105
        • Reclutamento
        • Smilow Cancer Hospital Care Center at Saint Francis
        • Contatto:
        • Investigatore principale:
          • Yifei Zhang
      • New Haven, Connecticut, Stati Uniti, 06520
        • Reclutamento
        • Yale University
        • Contatto:
        • Investigatore principale:
          • Yifei Zhang
      • North Haven, Connecticut, Stati Uniti, 06473
        • Reclutamento
        • Yale-New Haven Hospital North Haven Medical Center
        • Contatto:
        • Investigatore principale:
          • Yifei Zhang
      • Stamford, Connecticut, Stati Uniti, 06902
        • Reclutamento
        • Smilow Cancer Hospital Care Center at Long Ridge
        • Contatto:
        • Investigatore principale:
          • Yifei Zhang
      • Torrington, Connecticut, Stati Uniti, 06790
        • Reclutamento
        • Smilow Cancer Hospital-Torrington Care Center
        • Contatto:
        • Investigatore principale:
          • Yifei Zhang
      • Trumbull, Connecticut, Stati Uniti, 06611
        • Reclutamento
        • Smilow Cancer Hospital Care Center-Trumbull
        • Contatto:
        • Investigatore principale:
          • Yifei Zhang
      • Waterbury, Connecticut, Stati Uniti, 06708
        • Reclutamento
        • Smilow Cancer Hospital-Waterbury Care Center
        • Contatto:
        • Investigatore principale:
          • Yifei Zhang
      • Waterford, Connecticut, Stati Uniti, 06385
        • Reclutamento
        • Smilow Cancer Hospital Care Center - Waterford
        • Contatto:
        • Investigatore principale:
          • Yifei Zhang
    • Delaware
      • Millville, Delaware, Stati Uniti, 19967
        • Reclutamento
        • Beebe South Coastal Health Campus
        • Contatto:
        • Investigatore principale:
          • Gregory A. Masters
      • Newark, Delaware, Stati Uniti, 19713
        • Reclutamento
        • Helen F Graham Cancer Center
        • Investigatore principale:
          • Gregory A. Masters
        • Contatto:
      • Newark, Delaware, Stati Uniti, 19713
        • Reclutamento
        • Medical Oncology Hematology Consultants PA
        • Investigatore principale:
          • Gregory A. Masters
        • Contatto:
      • Rehoboth Beach, Delaware, Stati Uniti, 19971
        • Reclutamento
        • Beebe Health Campus
        • Contatto:
        • Investigatore principale:
          • Gregory A. Masters
    • District of Columbia
      • Washington D.C., District of Columbia, Stati Uniti, 20007
        • Reclutamento
        • MedStar Georgetown University Hospital
        • Investigatore principale:
          • Marcus S. Noel
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 202-444-2223
    • Florida
      • Miami Beach, Florida, Stati Uniti, 33140
        • Reclutamento
        • Mount Sinai Medical Center
        • Investigatore principale:
          • Mike Cusnir
        • Contatto:
      • Orlando, Florida, Stati Uniti, 32803
        • Reclutamento
        • AdventHealth Orlando
        • Contatto:
        • Investigatore principale:
          • Mohamedtaki A. Tejani
    • Georgia
      • Atlanta, Georgia, Stati Uniti, 30322
        • Reclutamento
        • Emory University Hospital/Winship Cancer Institute
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 404-778-1868
        • Investigatore principale:
          • Oluwadunni Emiloju
      • Atlanta, Georgia, Stati Uniti, 30308
        • Reclutamento
        • Emory University Hospital Midtown
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 888-946-7447
        • Investigatore principale:
          • Oluwadunni Emiloju
      • Atlanta, Georgia, Stati Uniti, 30342
        • Reclutamento
        • Emory Saint Joseph's Hospital
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 404-851-7115
        • Investigatore principale:
          • Oluwadunni Emiloju
      • Decatur, Georgia, Stati Uniti, 30033
      • Johns Creek, Georgia, Stati Uniti, 30097
        • Reclutamento
        • Emory Johns Creek Hospital
        • Contatto:
        • Investigatore principale:
          • Oluwadunni Emiloju
    • Hawaii
      • Honolulu, Hawaii, Stati Uniti, 96826
        • Reclutamento
        • Kapiolani Medical Center for Women and Children
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 808-983-6090
        • Investigatore principale:
          • Elizabeth S. Nakasone
      • Honolulu, Hawaii, Stati Uniti, 96813
        • Reclutamento
        • Hawaii Cancer Care Inc - Waterfront Plaza
        • Contatto:
        • Investigatore principale:
          • Elizabeth S. Nakasone
      • Honolulu, Hawaii, Stati Uniti, 96813
        • Reclutamento
        • Queen's Cancer Cenrer - POB I
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 808-532-0315
        • Investigatore principale:
          • Elizabeth S. Nakasone
      • Honolulu, Hawaii, Stati Uniti, 96813
        • Reclutamento
        • Queen's Medical Center
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 808-545-8548
        • Investigatore principale:
          • Elizabeth S. Nakasone
      • Honolulu, Hawaii, Stati Uniti, 96813
        • Reclutamento
        • Straub Clinic and Hospital
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 808-522-4333
        • Investigatore principale:
          • Elizabeth S. Nakasone
      • Honolulu, Hawaii, Stati Uniti, 96817
        • Reclutamento
        • Queen's Cancer Center - Kuakini
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 808-531-8521
        • Investigatore principale:
          • Elizabeth S. Nakasone
      • Honolulu, Hawaii, Stati Uniti, 96819
        • Reclutamento
        • Kaiser Permanente Moanalua Medical Center
        • Contatto:
        • Investigatore principale:
          • Tilak K. Sundaresan
      • ‘Aiea, Hawaii, Stati Uniti, 96701
        • Reclutamento
        • Hawaii Cancer Care - Westridge
        • Contatto:
        • Investigatore principale:
          • Elizabeth S. Nakasone
      • ‘Aiea, Hawaii, Stati Uniti, 96701
        • Reclutamento
        • Pali Momi Medical Center
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 808-486-6000
        • Investigatore principale:
          • Elizabeth S. Nakasone
      • ‘Ewa Beach, Hawaii, Stati Uniti, 96706
        • Reclutamento
        • The Queen's Medical Center - West Oahu
        • Contatto:
        • Investigatore principale:
          • Elizabeth S. Nakasone
    • Idaho
      • Boise, Idaho, Stati Uniti, 83706
        • Reclutamento
        • Saint Alphonsus Cancer Care Center-Boise
        • Contatto:
        • Investigatore principale:
          • Tareq Al baghdadi
      • Caldwell, Idaho, Stati Uniti, 83605
        • Reclutamento
        • Saint Alphonsus Cancer Care Center-Caldwell
        • Contatto:
        • Investigatore principale:
          • Tareq Al baghdadi
      • Coeur d'Alene, Idaho, Stati Uniti, 83814
        • Reclutamento
        • Kootenai Health - Coeur d'Alene
        • Investigatore principale:
          • John M. Schallenkamp
        • Contatto:
      • Nampa, Idaho, Stati Uniti, 83687
        • Reclutamento
        • Saint Alphonsus Cancer Care Center-Nampa
        • Contatto:
        • Investigatore principale:
          • Tareq Al baghdadi
      • Post Falls, Idaho, Stati Uniti, 83854
        • Reclutamento
        • Kootenai Clinic Cancer Services - Post Falls
        • Investigatore principale:
          • John M. Schallenkamp
        • Contatto:
      • Sandpoint, Idaho, Stati Uniti, 83864
        • Reclutamento
        • Kootenai Clinic Cancer Services - Sandpoint
        • Investigatore principale:
          • John M. Schallenkamp
        • Contatto:
    • Illinois
      • Aurora, Illinois, Stati Uniti, 60506
        • Reclutamento
        • Advocate Outpatient Center - Aurora
        • Investigatore principale:
          • Edward S. James
        • Contatto:
      • Aurora, Illinois, Stati Uniti, 60504
        • Sospeso
        • Rush-Copley Medical Center
      • Barrington, Illinois, Stati Uniti, 60010
        • Reclutamento
        • Advocate Good Shepherd Hospital
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 847-842-4847
        • Investigatore principale:
          • Edward S. James
      • Bloomington, Illinois, Stati Uniti, 61704
        • Sospeso
        • Illinois CancerCare-Bloomington
      • Canton, Illinois, Stati Uniti, 61520
        • Sospeso
        • Illinois CancerCare-Canton
      • Carthage, Illinois, Stati Uniti, 62321
        • Sospeso
        • Illinois CancerCare-Carthage
      • Chicago, Illinois, Stati Uniti, 60611
        • Reclutamento
        • Northwestern University
        • Contatto:
        • Investigatore principale:
          • Aparna Kalyan
      • Chicago, Illinois, Stati Uniti, 60612
        • Reclutamento
        • University of Illinois
        • Investigatore principale:
          • Yolande Chen
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 312-355-3046
      • Chicago, Illinois, Stati Uniti, 60657
        • Reclutamento
        • Advocate Illinois Masonic Medical Center
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 773-296-5360
        • Investigatore principale:
          • Edward S. James
      • Chicago, Illinois, Stati Uniti, 60625
        • Reclutamento
        • Swedish Covenant Hospital
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 773-878-8200
        • Investigatore principale:
          • Lauren A. Wiebe
      • Chicago, Illinois, Stati Uniti, 60637
        • Attivo, non reclutante
        • University of Chicago Comprehensive Cancer Center
      • Chicago, Illinois, Stati Uniti, 60641
        • Reclutamento
        • Northwestern Medicine Cancer Center Old Irving Park
        • Investigatore principale:
          • Aparna Kalyan
        • Contatto:
      • Crystal Lake, Illinois, Stati Uniti, 60014
        • Reclutamento
        • AMG Crystal Lake - Oncology
        • Contatto:
        • Investigatore principale:
          • Edward S. James
      • Danville, Illinois, Stati Uniti, 61832
        • Reclutamento
        • Carle at The Riverfront
        • Investigatore principale:
          • Suparna Mantha
        • Contatto:
      • DeKalb, Illinois, Stati Uniti, 60115
        • Reclutamento
        • Northwestern Medicine Cancer Center Kishwaukee
        • Contatto:
        • Investigatore principale:
          • Aparna Kalyan
      • Decatur, Illinois, Stati Uniti, 62526
        • Reclutamento
        • Cancer Care Specialists of Illinois - Decatur
        • Investigatore principale:
          • Bryan A. Faller
        • Contatto:
      • Decatur, Illinois, Stati Uniti, 62526
        • Reclutamento
        • Decatur Memorial Hospital
        • Investigatore principale:
          • Bryan A. Faller
        • Contatto:
      • Dixon, Illinois, Stati Uniti, 61021
        • Sospeso
        • Illinois CancerCare-Dixon
      • Downers Grove, Illinois, Stati Uniti, 60515
        • Reclutamento
        • Advocate Good Samaritan Hospital
        • Contatto:
        • Investigatore principale:
          • Edward S. James
      • Effingham, Illinois, Stati Uniti, 62401
        • Reclutamento
        • Carle Physician Group-Effingham
        • Investigatore principale:
          • Suparna Mantha
        • Contatto:
      • Effingham, Illinois, Stati Uniti, 62401
        • Reclutamento
        • Crossroads Cancer Center
        • Investigatore principale:
          • Bryan A. Faller
        • Contatto:
      • Elgin, Illinois, Stati Uniti, 60123
        • Reclutamento
        • Advocate Sherman Hospital
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 847-429-2907
        • Investigatore principale:
          • Edward S. James
      • Eureka, Illinois, Stati Uniti, 61530
        • Sospeso
        • Illinois CancerCare-Eureka
      • Evanston, Illinois, Stati Uniti, 60201
        • Reclutamento
        • NorthShore University HealthSystem-Evanston Hospital
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 847-570-2109
        • Investigatore principale:
          • Lauren A. Wiebe
      • Galesburg, Illinois, Stati Uniti, 61401
        • Sospeso
        • Illinois CancerCare-Galesburg
      • Geneva, Illinois, Stati Uniti, 60134
        • Reclutamento
        • Northwestern Medicine Cancer Center Delnor
        • Contatto:
        • Investigatore principale:
          • Aparna Kalyan
      • Glenview, Illinois, Stati Uniti, 60026
        • Reclutamento
        • NorthShore University HealthSystem-Glenbrook Hospital
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 847-570-2109
        • Investigatore principale:
          • Lauren A. Wiebe
      • Glenview, Illinois, Stati Uniti, 60026
        • Reclutamento
        • Northwestern Medicine Glenview Outpatient Center
        • Investigatore principale:
          • Aparna Kalyan
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 312-695-1102
      • Grayslake, Illinois, Stati Uniti, 60030
        • Reclutamento
        • Northwestern Medicine Grayslake Outpatient Center
        • Investigatore principale:
          • Aparna Kalyan
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 312-695-1102
      • Harvey, Illinois, Stati Uniti, 60426
        • Attivo, non reclutante
        • Ingalls Memorial Hospital
      • Hazel Crest, Illinois, Stati Uniti, 60429
        • Reclutamento
        • Advocate South Suburban Hospital
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 708-799-9995
        • Investigatore principale:
          • Edward S. James
      • Highland Park, Illinois, Stati Uniti, 60035
        • Reclutamento
        • NorthShore University HealthSystem-Highland Park Hospital
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 847-570-2109
        • Investigatore principale:
          • Lauren A. Wiebe
      • Kewanee, Illinois, Stati Uniti, 61443
        • Sospeso
        • Illinois CancerCare-Kewanee Clinic
      • Lake Forest, Illinois, Stati Uniti, 60045
        • Reclutamento
        • Northwestern Medicine Lake Forest Hospital
        • Contatto:
        • Investigatore principale:
          • Aparna Kalyan
      • Libertyville, Illinois, Stati Uniti, 60048
        • Reclutamento
        • AMG Libertyville - Oncology
        • Contatto:
        • Investigatore principale:
          • Edward S. James
      • Libertyville, Illinois, Stati Uniti, 60048
        • Reclutamento
        • Condell Memorial Hospital
        • Contatto:
        • Investigatore principale:
          • Edward S. James
      • Macomb, Illinois, Stati Uniti, 61455
        • Sospeso
        • Illinois CancerCare-Macomb
      • Mattoon, Illinois, Stati Uniti, 61938
        • Reclutamento
        • Carle Physician Group-Mattoon/Charleston
        • Investigatore principale:
          • Suparna Mantha
        • Contatto:
      • New Lenox, Illinois, Stati Uniti, 60451
        • Attivo, non reclutante
        • UC Comprehensive Cancer Center at Silver Cross
      • O'Fallon, Illinois, Stati Uniti, 62269
        • Reclutamento
        • Cancer Care Center of O'Fallon
        • Investigatore principale:
          • Bryan A. Faller
        • Contatto:
      • Oak Brook, Illinois, Stati Uniti, 60523
      • Oak Lawn, Illinois, Stati Uniti, 60453-2699
        • Reclutamento
        • Advocate Christ Medical Center
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 800-323-8622
        • Investigatore principale:
          • Edward S. James
      • Orland Park, Illinois, Stati Uniti, 60462
        • Attivo, non reclutante
        • University of Chicago Medicine-Orland Park
      • Orland Park, Illinois, Stati Uniti, 60462
      • Ottawa, Illinois, Stati Uniti, 61350
        • Sospeso
        • Illinois CancerCare-Ottawa Clinic
      • Park Ridge, Illinois, Stati Uniti, 60068
        • Reclutamento
        • Advocate Lutheran General Hospital
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 847-384-3621
        • Investigatore principale:
          • Edward S. James
      • Pekin, Illinois, Stati Uniti, 61554
        • Sospeso
        • Illinois CancerCare-Pekin
      • Peoria, Illinois, Stati Uniti, 61615
        • Sospeso
        • Illinois CancerCare-Peoria
      • Peru, Illinois, Stati Uniti, 61354
        • Sospeso
        • Illinois CancerCare-Peru
      • Princeton, Illinois, Stati Uniti, 61356
        • Sospeso
        • Illinois CancerCare-Princeton
      • Rockford, Illinois, Stati Uniti, 61114
        • Reclutamento
        • UW Health Carbone Cancer Center Rockford
        • Contatto:
        • Investigatore principale:
          • Fahrettin Covut
      • Rockford, Illinois, Stati Uniti, 61114
        • Reclutamento
        • Mercyhealth Cancer Institute - Rockford
        • Investigatore principale:
          • Mayur Narkhede
        • Contatto:
      • Shiloh, Illinois, Stati Uniti, 62269
        • Reclutamento
        • Memorial Hospital East
        • Contatto:
        • Investigatore principale:
          • Patrick Grierson
      • Springfield, Illinois, Stati Uniti, 62702
        • Reclutamento
        • Southern Illinois University School of Medicine
        • Investigatore principale:
          • Bryan A. Faller
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 217-545-7929
      • Springfield, Illinois, Stati Uniti, 62702
        • Reclutamento
        • Springfield Clinic
        • Investigatore principale:
          • Bryan A. Faller
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 800-444-7541
      • Springfield, Illinois, Stati Uniti, 62781
        • Reclutamento
        • Springfield Memorial Hospital
        • Investigatore principale:
          • Bryan A. Faller
        • Contatto:
      • Urbana, Illinois, Stati Uniti, 61801
        • Reclutamento
        • Carle Cancer Center
        • Investigatore principale:
          • Suparna Mantha
        • Contatto:
      • Warrenville, Illinois, Stati Uniti, 60555
        • Reclutamento
        • Northwestern Medicine Cancer Center Warrenville
        • Contatto:
        • Investigatore principale:
          • Aparna Kalyan
      • Washington, Illinois, Stati Uniti, 61571
        • Sospeso
        • Illinois CancerCare - Washington
    • Indiana
      • Crown Point, Indiana, Stati Uniti, 46307
        • Attivo, non reclutante
        • UChicago Medicine Northwest Indiana
      • Crown Point, Indiana, Stati Uniti, 46307
        • Reclutamento
        • Northwest Cancer Center - Crown Point
        • Investigatore principale:
          • Suparna Mantha
        • Contatto:
      • Dyer, Indiana, Stati Uniti, 46311
        • Reclutamento
        • Northwest Oncology LLC
        • Investigatore principale:
          • Suparna Mantha
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 219-924-8178
      • Hobart, Indiana, Stati Uniti, 46342
        • Reclutamento
        • Northwest Cancer Center - Hobart
        • Investigatore principale:
          • Suparna Mantha
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 219-947-1795
      • Hobart, Indiana, Stati Uniti, 46342
        • Reclutamento
        • Saint Mary Medical Center
        • Investigatore principale:
          • Suparna Mantha
        • Contatto:
      • Indianapolis, Indiana, Stati Uniti, 46312
        • Reclutamento
        • Saint Catherine Hospital
        • Investigatore principale:
          • Suparna Mantha
        • Contatto:
      • Munster, Indiana, Stati Uniti, 46321
        • Reclutamento
        • The Community Hospital
        • Investigatore principale:
          • Suparna Mantha
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 219-836-3349
      • Munster, Indiana, Stati Uniti, 46321
        • Reclutamento
        • Women's Diagnostic Center - Munster
        • Investigatore principale:
          • Suparna Mantha
        • Contatto:
      • Valparaiso, Indiana, Stati Uniti, 46383
        • Reclutamento
        • Northwest Cancer Center - Valparaiso
        • Investigatore principale:
          • Suparna Mantha
        • Contatto:
    • Iowa
      • Ankeny, Iowa, Stati Uniti, 50023
        • Reclutamento
        • UI Health Care Mission Cancer and Blood - Ankeny Clinic
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 515-241-3305
        • Investigatore principale:
          • Seema Harichand-Herdt
      • Carroll, Iowa, Stati Uniti, 51401
        • Reclutamento
        • Saint Anthony Regional Hospital
        • Contatto:
        • Investigatore principale:
          • Seema Harichand-Herdt
      • Cedar Rapids, Iowa, Stati Uniti, 52403
        • Reclutamento
        • Mercy Hospital
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 319-365-4673
        • Investigatore principale:
          • Deborah W. Wilbur
      • Cedar Rapids, Iowa, Stati Uniti, 52403
        • Reclutamento
        • Oncology Associates at Mercy Medical Center
        • Investigatore principale:
          • Deborah W. Wilbur
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 319-363-2690
      • Clive, Iowa, Stati Uniti, 50325
        • Reclutamento
        • UI Health Care Mission Cancer and Blood - West Des Moines Clinic
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 515-241-3305
        • Investigatore principale:
          • Seema Harichand-Herdt
      • Des Moines, Iowa, Stati Uniti, 50314
        • Reclutamento
        • Broadlawns Medical Center
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 515-282-2200
        • Investigatore principale:
          • Seema Harichand-Herdt
      • Des Moines, Iowa, Stati Uniti, 50309
        • Reclutamento
        • Iowa Methodist Medical Center
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 515-241-6727
        • Investigatore principale:
          • Seema Harichand-Herdt
      • Des Moines, Iowa, Stati Uniti, 50309
        • Reclutamento
        • UI Health Care Mission Cancer and Blood - Des Moines Clinic
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 515-241-3305
        • Investigatore principale:
          • Seema Harichand-Herdt
      • Des Moines, Iowa, Stati Uniti, 50314
        • Reclutamento
        • UI Health Care Mission Cancer and Blood - Laurel Clinic
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 515-241-3305
        • Investigatore principale:
          • Seema Harichand-Herdt
      • Fort Dodge, Iowa, Stati Uniti, 50501
        • Reclutamento
        • UI Healthcare Mission Cancer and Blood - Fort Dodge
        • Investigatore principale:
          • Seema Harichand-Herdt
        • Contatto:
      • Waukee, Iowa, Stati Uniti, 50263
        • Reclutamento
        • UI Health Care Mission Cancer and Blood - Waukee Clinic
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 515-241-3305
        • Investigatore principale:
          • Seema Harichand-Herdt
    • Kansas
      • Hays, Kansas, Stati Uniti, 67601
        • Reclutamento
        • HaysMed
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 785-623-5774
        • Investigatore principale:
          • Gary C. Doolittle
      • Lawrence, Kansas, Stati Uniti, 66044
        • Reclutamento
        • Lawrence Memorial Hospital
        • Contatto:
        • Investigatore principale:
          • Gary C. Doolittle
      • Olathe, Kansas, Stati Uniti, 66061
        • Reclutamento
        • The University of Kansas Cancer Center - Olathe
        • Investigatore principale:
          • Gary C. Doolittle
        • Contatto:
      • Salina, Kansas, Stati Uniti, 67401
        • Reclutamento
        • Salina Regional Health Center
        • Contatto:
        • Investigatore principale:
          • Gary C. Doolittle
      • Topeka, Kansas, Stati Uniti, 66606
        • Reclutamento
        • University of Kansas Health System Saint Francis Campus
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 785-295-8000
        • Investigatore principale:
          • Gary C. Doolittle
    • Kentucky
      • Lexington, Kentucky, Stati Uniti, 40509
        • Attivo, non reclutante
        • CommonSpirit Saint Joseph Medical Center - East Lexington
    • Louisiana
      • Covington, Louisiana, Stati Uniti, 70433
        • Reclutamento
        • Ochsner Hematology Oncology North Shore - Covington (West Region)
        • Investigatore principale:
          • Jonathan D. Mizrahi
        • Contatto:
      • New Orleans, Louisiana, Stati Uniti, 70121
        • Reclutamento
        • Ochsner Medical Center Jefferson
        • Investigatore principale:
          • Jonathan D. Mizrahi
        • Contatto:
    • Maryland
      • Cumberland, Maryland, Stati Uniti, 21502
        • Reclutamento
        • UPMC Western Maryland
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 240-964-1400
        • Investigatore principale:
          • Anwaar Saeed
    • Michigan
      • Ann Arbor, Michigan, Stati Uniti, 48106
        • Reclutamento
        • Trinity Health Saint Joseph Mercy Hospital Ann Arbor
        • Contatto:
        • Investigatore principale:
          • Tareq Al baghdadi
      • Brighton, Michigan, Stati Uniti, 48114
        • Reclutamento
        • Trinity Health IHA Medical Group Hematology Oncology - Brighton
        • Contatto:
        • Investigatore principale:
          • Tareq Al baghdadi
      • Brighton, Michigan, Stati Uniti, 48114
        • Reclutamento
        • Trinity Health Medical Center - Brighton
        • Contatto:
        • Investigatore principale:
          • Tareq Al baghdadi
      • Brownstown, Michigan, Stati Uniti, 48183
        • Reclutamento
        • Henry Ford Cancer Institute-Downriver
        • Contatto:
        • Investigatore principale:
          • Gazala Khan
      • Canton, Michigan, Stati Uniti, 48188
        • Reclutamento
        • Trinity Health IHA Medical Group Hematology Oncology - Canton
        • Contatto:
        • Investigatore principale:
          • Tareq Al baghdadi
      • Canton, Michigan, Stati Uniti, 48188
        • Reclutamento
        • Trinity Health Medical Center - Canton
        • Contatto:
        • Investigatore principale:
          • Tareq Al baghdadi
      • Chelsea, Michigan, Stati Uniti, 48118
        • Reclutamento
        • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital
        • Contatto:
        • Investigatore principale:
          • Tareq Al baghdadi
      • Chelsea, Michigan, Stati Uniti, 48118
      • Clinton Township, Michigan, Stati Uniti, 48038
        • Reclutamento
        • Henry Ford Macomb Hospital-Clinton Township
        • Contatto:
        • Investigatore principale:
          • Gazala Khan
      • Dearborn, Michigan, Stati Uniti, 48126
        • Reclutamento
        • Henry Ford Medical Center-Fairlane
        • Contatto:
        • Investigatore principale:
          • Gazala Khan
      • Detroit, Michigan, Stati Uniti, 48202
        • Reclutamento
        • Henry Ford Hospital
        • Contatto:
        • Investigatore principale:
          • Gazala Khan
      • Escanaba, Michigan, Stati Uniti, 49829
        • Reclutamento
        • OSF Saint Francis Hospital and Medical Group
        • Investigatore principale:
          • Matthew L. Ryan
        • Contatto:
      • Flint, Michigan, Stati Uniti, 48503
        • Reclutamento
        • Genesys Hurley Cancer Institute
        • Contatto:
        • Investigatore principale:
          • Tareq Al baghdadi
      • Flint, Michigan, Stati Uniti, 48503
        • Reclutamento
        • Hurley Medical Center
        • Contatto:
        • Investigatore principale:
          • Tareq Al baghdadi
      • Flint, Michigan, Stati Uniti, 48503
        • Sospeso
        • Genesee Hematology Oncology PC
      • Flint, Michigan, Stati Uniti, 48503
        • Reclutamento
        • Cancer Hematology Centers - Flint
        • Contatto:
        • Investigatore principale:
          • Tareq Al baghdadi
      • Jackson, Michigan, Stati Uniti, 49201
        • Reclutamento
        • Allegiance Health
        • Contatto:
        • Investigatore principale:
          • Gazala Khan
      • Lansing, Michigan, Stati Uniti, 48912
        • Reclutamento
        • University of Michigan Health - Sparrow Lansing
        • Investigatore principale:
          • Tareq Al baghdadi
        • Contatto:
      • Livonia, Michigan, Stati Uniti, 48154
        • Reclutamento
        • Trinity Health Saint Mary Mercy Livonia Hospital
        • Contatto:
        • Investigatore principale:
          • Tareq Al baghdadi
      • Novi, Michigan, Stati Uniti, 48377
        • Reclutamento
        • Henry Ford Medical Center-Columbus
        • Contatto:
        • Investigatore principale:
          • Gazala Khan
      • Novi, Michigan, Stati Uniti, 48374
        • Sospeso
        • Henry Ford Health Providence Novi Hospital
      • Pontiac, Michigan, Stati Uniti, 48341
        • Reclutamento
        • Trinity Health Saint Joseph Mercy Oakland Hospital
        • Contatto:
        • Investigatore principale:
          • Tareq Al baghdadi
      • Southfield, Michigan, Stati Uniti, 48075
        • Sospeso
        • Henry Ford Health Providence Southfield Hospital
      • West Bloomfield, Michigan, Stati Uniti, 48322
        • Reclutamento
        • Henry Ford West Bloomfield Hospital
        • Contatto:
        • Investigatore principale:
          • Gazala Khan
      • Wyandotte, Michigan, Stati Uniti, 48192
        • Reclutamento
        • Henry Ford Wyandotte Hospital
        • Contatto:
        • Investigatore principale:
          • Gazala Khan
      • Ypsilanti, Michigan, Stati Uniti, 48197
        • Reclutamento
        • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus
        • Contatto:
        • Investigatore principale:
          • Tareq Al baghdadi
    • Minnesota
      • Bemidji, Minnesota, Stati Uniti, 56601
      • Brainerd, Minnesota, Stati Uniti, 56401
        • Reclutamento
        • Essentia Health Saint Joseph's Medical Center
        • Contatto:
        • Investigatore principale:
          • Bret E. Friday
      • Coon Rapids, Minnesota, Stati Uniti, 55433
        • Reclutamento
        • Mercy Hospital
        • Contatto:
        • Investigatore principale:
          • David M. King
      • Deer River, Minnesota, Stati Uniti, 56636
        • Reclutamento
        • Essentia Health - Deer River Clinic
        • Contatto:
        • Investigatore principale:
          • Bret E. Friday
      • Duluth, Minnesota, Stati Uniti, 55805
        • Reclutamento
        • Essentia Health Cancer Center
        • Contatto:
        • Investigatore principale:
          • Bret E. Friday
      • Edina, Minnesota, Stati Uniti, 55435
        • Reclutamento
        • Fairview Southdale Hospital
        • Contatto:
        • Investigatore principale:
          • David M. King
      • Edina, Minnesota, Stati Uniti, 55435
        • Reclutamento
        • Minnesota Oncology - Edina
        • Contatto:
        • Investigatore principale:
          • David M. King
      • Hibbing, Minnesota, Stati Uniti, 55746
        • Reclutamento
        • Essentia Health Hibbing Clinic
        • Investigatore principale:
          • Bret E. Friday
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 218-786-3308
      • Maplewood, Minnesota, Stati Uniti, 55109
        • Reclutamento
        • Saint John's Hospital - Healtheast
        • Contatto:
        • Investigatore principale:
          • David M. King
      • Minneapolis, Minnesota, Stati Uniti, 55407
        • Reclutamento
        • Abbott-Northwestern Hospital
        • Contatto:
        • Investigatore principale:
          • David M. King
      • Saint Louis Park, Minnesota, Stati Uniti, 55416
        • Reclutamento
        • Park Nicollet Clinic - Saint Louis Park
        • Contatto:
        • Investigatore principale:
          • David M. King
      • Saint Paul, Minnesota, Stati Uniti, 55101
        • Reclutamento
        • Regions Hospital
        • Contatto:
        • Investigatore principale:
          • David M. King
      • Saint Paul, Minnesota, Stati Uniti, 55102
        • Reclutamento
        • United Hospital
        • Contatto:
        • Investigatore principale:
          • David M. King
      • Sandstone, Minnesota, Stati Uniti, 55072
        • Reclutamento
        • Essentia Health Sandstone
        • Contatto:
        • Investigatore principale:
          • Bret E. Friday
      • Virginia, Minnesota, Stati Uniti, 55792
        • Reclutamento
        • Essentia Health Virginia Clinic
        • Contatto:
        • Investigatore principale:
          • Bret E. Friday
      • Woodbury, Minnesota, Stati Uniti, 55125
        • Reclutamento
        • Minnesota Oncology Hematology PA-Woodbury
        • Contatto:
        • Investigatore principale:
          • David M. King
    • Missouri
      • Cape Girardeau, Missouri, Stati Uniti, 63703
        • Reclutamento
        • Saint Francis Medical Center
        • Investigatore principale:
          • Bryan A. Faller
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 573-334-2230
          • Email: sfmc@sfmc.net
      • City of Saint Peters, Missouri, Stati Uniti, 63376
        • Reclutamento
        • Siteman Cancer Center at Saint Peters Hospital
        • Contatto:
        • Investigatore principale:
          • Patrick Grierson
      • Creve Coeur, Missouri, Stati Uniti, 63141
        • Reclutamento
        • Siteman Cancer Center at West County Hospital
        • Contatto:
        • Investigatore principale:
          • Patrick Grierson
      • Kansas City, Missouri, Stati Uniti, 64108
        • Reclutamento
        • University Health Truman Medical Center
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 816-404-4375
        • Investigatore principale:
          • Gary C. Doolittle
      • St Louis, Missouri, Stati Uniti, 63110
        • Reclutamento
        • Washington University School of Medicine
        • Contatto:
        • Investigatore principale:
          • Patrick Grierson
      • St Louis, Missouri, Stati Uniti, 63129
        • Reclutamento
        • Siteman Cancer Center-South County
        • Contatto:
        • Investigatore principale:
          • Patrick Grierson
      • St Louis, Missouri, Stati Uniti, 63136
        • Reclutamento
        • Siteman Cancer Center at Christian Hospital
        • Contatto:
        • Investigatore principale:
          • Patrick Grierson
    • Montana
      • Anaconda, Montana, Stati Uniti, 59711
        • Reclutamento
        • Community Hospital of Anaconda
        • Investigatore principale:
          • John M. Schallenkamp
        • Contatto:
      • Billings, Montana, Stati Uniti, 59101
        • Reclutamento
        • Billings Clinic Cancer Center
        • Investigatore principale:
          • John M. Schallenkamp
        • Contatto:
      • Billings, Montana, Stati Uniti, 59102
        • Reclutamento
        • Saint Vincent Frontier Cancer Center
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 800-648-6274
        • Investigatore principale:
          • Patrick W. Cobb
      • Bozeman, Montana, Stati Uniti, 59715
        • Reclutamento
        • Bozeman Health Deaconess Hospital
        • Investigatore principale:
          • John M. Schallenkamp
        • Contatto:
      • Great Falls, Montana, Stati Uniti, 59405
        • Reclutamento
        • Benefis Sletten Cancer Institute
        • Investigatore principale:
          • John M. Schallenkamp
        • Contatto:
      • Kalispell, Montana, Stati Uniti, 59901
        • Reclutamento
        • Logan Health Medical Center
        • Investigatore principale:
          • John M. Schallenkamp
        • Contatto:
      • Missoula, Montana, Stati Uniti, 59804
        • Reclutamento
        • Community Medical Center
        • Investigatore principale:
          • John M. Schallenkamp
        • Contatto:
    • Nebraska
      • Bellevue, Nebraska, Stati Uniti, 68123
        • Reclutamento
        • Nebraska Medicine-Bellevue
        • Contatto:
        • Investigatore principale:
          • Mridula Krishnan
      • Omaha, Nebraska, Stati Uniti, 68198
        • Reclutamento
        • University of Nebraska Medical Center
        • Contatto:
        • Investigatore principale:
          • Mridula Krishnan
      • Omaha, Nebraska, Stati Uniti, 68118
        • Reclutamento
        • Nebraska Medicine-Village Pointe
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 402-559-5600
        • Investigatore principale:
          • Mridula Krishnan
    • Nevada
      • Las Vegas, Nevada, Stati Uniti, 89102
        • Sospeso
        • OptumCare Cancer Care at Charleston
      • Las Vegas, Nevada, Stati Uniti, 89183
        • Sospeso
        • OptumCare Cancer Care at Fort Apache
      • Reno, Nevada, Stati Uniti, 89502
        • Sospeso
        • Renown Regional Medical Center
    • New Jersey
      • Cherry Hill, New Jersey, Stati Uniti, 08002
        • Reclutamento
        • Jefferson Cherry Hill Hospital
        • Contatto:
        • Investigatore principale:
          • Daniel Lin
      • Englewood, New Jersey, Stati Uniti, 07631
        • Attivo, non reclutante
        • Englewood Hospital and Medical Center
      • Sewell, New Jersey, Stati Uniti, 08080
        • Reclutamento
        • Sidney Kimmel Cancer Center Washington Township
        • Contatto:
        • Investigatore principale:
          • Daniel Lin
    • New Mexico
      • Albuquerque, New Mexico, Stati Uniti, 87102
        • Reclutamento
        • Lovelace Medical Center-Saint Joseph Square
        • Investigatore principale:
          • Jessica Belmonte
        • Contatto:
      • Albuquerque, New Mexico, Stati Uniti, 87106
        • Reclutamento
        • University of New Mexico Cancer Center
        • Contatto:
        • Investigatore principale:
          • Jessica Belmonte
    • New York
      • Bay Shore, New York, Stati Uniti, 11706
        • Reclutamento
        • Northwell Health Imbert Cancer Center
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 516-734-8896
        • Investigatore principale:
          • Crystal Antoine-Pepeljugoski
      • Buffalo, New York, Stati Uniti, 14263
        • Reclutamento
        • Roswell Park Cancer Institute
        • Investigatore principale:
          • Kannan Thanikachalam
        • Contatto:
      • Glens Falls, New York, Stati Uniti, 12801
        • Attivo, non reclutante
        • Glens Falls Hospital
      • Greenlawn, New York, Stati Uniti, 11740
        • Reclutamento
        • Northwell Health Cancer Institute at Huntington
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 516-734-8896
        • Investigatore principale:
          • Crystal Antoine-Pepeljugoski
      • Lake Success, New York, Stati Uniti, 11042
        • Reclutamento
        • Northwell Health/Center for Advanced Medicine
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 516-734-8896
        • Investigatore principale:
          • Crystal Antoine-Pepeljugoski
      • Mineola, New York, Stati Uniti, 11501
        • Reclutamento
        • NYU Langone Hospital - Long Island
        • Contatto:
        • Investigatore principale:
          • Jennifer W. Chuy
      • Mount Kisco, New York, Stati Uniti, 10549
        • Reclutamento
        • Northern Westchester Hospital
        • Contatto:
        • Investigatore principale:
          • Crystal Antoine-Pepeljugoski
      • New York, New York, Stati Uniti, 10016
        • Reclutamento
        • Laura and Isaac Perlmutter Cancer Center at NYU Langone
        • Contatto:
        • Investigatore principale:
          • Jennifer W. Chuy
      • Rochester, New York, Stati Uniti, 14642
        • Reclutamento
        • University of Rochester
        • Investigatore principale:
          • Richard F. Dunne
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 585-275-5830
      • Sleepy Hollow, New York, Stati Uniti, 10591
        • Reclutamento
        • Phelps Memorial Hospital Center
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 914-366-1600
        • Investigatore principale:
          • Crystal Antoine-Pepeljugoski
      • Williamsville, New York, Stati Uniti, 14221
        • Reclutamento
        • Roswell Park Amherst Center
        • Investigatore principale:
          • Kannan Thanikachalam
        • Contatto:
    • North Carolina
      • Asheboro, North Carolina, Stati Uniti, 27203
        • Sospeso
        • Cone Health Cancer Center at Asheboro
      • Asheboro, North Carolina, Stati Uniti, 27205
        • Reclutamento
        • Cone Health MedCenter Asheboro
        • Contatto:
        • Investigatore principale:
          • Vinay K. Gudena
      • Burlington, North Carolina, Stati Uniti, 27215
        • Reclutamento
        • Cone Health Cancer Center at Alamance Regional
        • Contatto:
        • Investigatore principale:
          • Vinay K. Gudena
      • Clinton, North Carolina, Stati Uniti, 28328
        • Reclutamento
        • Southeastern Medical Oncology Center-Clinton
        • Contatto:
        • Investigatore principale:
          • Samer S. Kasbari
      • Goldsboro, North Carolina, Stati Uniti, 27534
        • Reclutamento
        • Southeastern Medical Oncology Center-Goldsboro
        • Contatto:
        • Investigatore principale:
          • Samer S. Kasbari
      • Greensboro, North Carolina, Stati Uniti, 27403
        • Reclutamento
        • Cone Health Cancer Center
        • Contatto:
        • Investigatore principale:
          • Vinay K. Gudena
      • Greensboro, North Carolina, Stati Uniti, 27410
        • Reclutamento
        • Cone Health Cancer Center at Drawbridge Parkway
        • Contatto:
        • Investigatore principale:
          • Vinay K. Gudena
      • Jacksonville, North Carolina, Stati Uniti, 28546
        • Reclutamento
        • Southeastern Medical Oncology Center-Jacksonville
        • Investigatore principale:
          • Samer S. Kasbari
        • Contatto:
      • Pinehurst, North Carolina, Stati Uniti, 28374
        • Reclutamento
        • FirstHealth of the Carolinas-Moore Regional Hospital
        • Contatto:
        • Investigatore principale:
          • Charles S. Kuzma
      • Reidsville, North Carolina, Stati Uniti, 27320
        • Reclutamento
        • Annie Penn Memorial Hospital
        • Contatto:
        • Investigatore principale:
          • Vinay K. Gudena
    • North Dakota
      • Bismarck, North Dakota, Stati Uniti, 58501
      • Fargo, North Dakota, Stati Uniti, 58122
      • Fargo, North Dakota, Stati Uniti, 58103
        • Reclutamento
        • Essentia Health Cancer Center-South University Clinic
        • Contatto:
        • Investigatore principale:
          • Bret E. Friday
      • Fargo, North Dakota, Stati Uniti, 58122
    • Ohio
      • Centerville, Ohio, Stati Uniti, 45459
        • Reclutamento
        • Miami Valley Hospital South
        • Contatto:
        • Investigatore principale:
          • Tarek M. Sabagh
      • Cincinnati, Ohio, Stati Uniti, 45220
        • Attivo, non reclutante
        • Good Samaritan Hospital - Cincinnati
      • Dayton, Ohio, Stati Uniti, 45409
        • Reclutamento
        • Miami Valley Hospital
        • Contatto:
        • Investigatore principale:
          • Tarek M. Sabagh
      • Dayton, Ohio, Stati Uniti, 45415
        • Reclutamento
        • Miami Valley Hospital North
        • Contatto:
        • Investigatore principale:
          • Tarek M. Sabagh
      • Dayton, Ohio, Stati Uniti, 45409
        • Reclutamento
        • Premier Blood and Cancer Center
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 937-276-8320
        • Investigatore principale:
          • Tarek M. Sabagh
      • Franklin, Ohio, Stati Uniti, 45005-1066
        • Reclutamento
        • Atrium Medical Center-Middletown Regional Hospital
        • Contatto:
        • Investigatore principale:
          • Tarek M. Sabagh
      • Greenville, Ohio, Stati Uniti, 45331
        • Reclutamento
        • Miami Valley Cancer Care and Infusion
        • Investigatore principale:
          • Tarek M. Sabagh
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 937-569-7515
      • Troy, Ohio, Stati Uniti, 45373
        • Reclutamento
        • Upper Valley Medical Center
        • Contatto:
        • Investigatore principale:
          • Tarek M. Sabagh
    • Oklahoma
      • Lawton, Oklahoma, Stati Uniti, 73505
        • Reclutamento
        • Cancer Centers of Southwest Oklahoma Research
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 877-231-4440
        • Investigatore principale:
          • Hassan Hatoum
      • Oklahoma City, Oklahoma, Stati Uniti, 73104
        • Reclutamento
        • University of Oklahoma Health Sciences Center
        • Contatto:
        • Investigatore principale:
          • Hassan Hatoum
      • Oklahoma City, Oklahoma, Stati Uniti, 73109
        • Sospeso
        • Integris Southwest Medical Center
      • Oklahoma City, Oklahoma, Stati Uniti, 73142
        • Sospeso
        • Integris Cancer Institute of Oklahoma
      • Tulsa, Oklahoma, Stati Uniti, 74146
        • Attivo, non reclutante
        • Oklahoma Cancer Specialists and Research Institute-Tulsa
    • Oregon
      • Newberg, Oregon, Stati Uniti, 97132
        • Reclutamento
        • Providence Newberg Medical Center
        • Contatto:
        • Investigatore principale:
          • Charles W. Drescher
      • Ontario, Oregon, Stati Uniti, 97914
        • Reclutamento
        • Saint Alphonsus Cancer Care Center-Ontario
        • Contatto:
        • Investigatore principale:
          • Tareq Al baghdadi
      • Oregon City, Oregon, Stati Uniti, 97045
        • Reclutamento
        • Providence Willamette Falls Medical Center
        • Contatto:
        • Investigatore principale:
          • Charles W. Drescher
      • Portland, Oregon, Stati Uniti, 97239
        • Reclutamento
        • Oregon Health and Science University
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 503-494-1080
          • Email: trials@ohsu.edu
        • Investigatore principale:
          • Emerson Y. Chen
      • Portland, Oregon, Stati Uniti, 97213
        • Reclutamento
        • Providence Portland Medical Center
        • Contatto:
        • Investigatore principale:
          • Charles W. Drescher
      • Portland, Oregon, Stati Uniti, 97225
        • Reclutamento
        • Providence Saint Vincent Medical Center
        • Contatto:
        • Investigatore principale:
          • Charles W. Drescher
    • Pennsylvania
      • Allentown, Pennsylvania, Stati Uniti, 18103
        • Reclutamento
        • Lehigh Valley Hospital-Cedar Crest
        • Contatto:
        • Investigatore principale:
          • Tareq Al baghdadi
      • Beaver, Pennsylvania, Stati Uniti, 15009
        • Reclutamento
        • UPMC-Heritage Valley Health System Beaver
        • Contatto:
        • Investigatore principale:
          • Anwaar Saeed
      • Bethlehem, Pennsylvania, Stati Uniti, 18017
        • Reclutamento
        • Lehigh Valley Hospital - Muhlenberg
        • Contatto:
        • Investigatore principale:
          • Tareq Al baghdadi
      • Danville, Pennsylvania, Stati Uniti, 17822
        • Reclutamento
        • Geisinger Medical Center
        • Investigatore principale:
          • Mina Makary
        • Contatto:
      • Dickson City, Pennsylvania, Stati Uniti, 18519
        • Reclutamento
        • Geisinger Cancer Center Dickson City
        • Investigatore principale:
          • Mina Makary
        • Contatto:
      • East Stroudsburg, Pennsylvania, Stati Uniti, 18301
        • Reclutamento
        • Pocono Medical Center
        • Contatto:
        • Investigatore principale:
          • Tareq Al baghdadi
      • Erie, Pennsylvania, Stati Uniti, 16505
        • Reclutamento
        • UPMC Hillman Cancer Center Erie
        • Investigatore principale:
          • Anwaar Saeed
        • Contatto:
      • Greensburg, Pennsylvania, Stati Uniti, 15601
        • Reclutamento
        • UPMC Cancer Centers - Arnold Palmer Pavilion
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 724-838-1900
        • Investigatore principale:
          • Anwaar Saeed
      • Harrisburg, Pennsylvania, Stati Uniti, 17109
        • Reclutamento
        • UPMC Pinnacle Cancer Center/Community Osteopathic Campus
        • Contatto:
        • Investigatore principale:
          • Anwaar Saeed
      • Hazleton, Pennsylvania, Stati Uniti, 18201
        • Reclutamento
        • Lehigh Valley Hospital-Hazleton
        • Contatto:
        • Investigatore principale:
          • Tareq Al baghdadi
      • Johnstown, Pennsylvania, Stati Uniti, 15901
        • Reclutamento
        • UPMC-Johnstown/John P. Murtha Regional Cancer Center
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 814-534-4724
        • Investigatore principale:
          • Anwaar Saeed
      • Lancaster, Pennsylvania, Stati Uniti, 17601
        • Attivo, non reclutante
        • Lancaster General Ann B Barshinger Cancer Institute
      • Lewisburg, Pennsylvania, Stati Uniti, 17837
        • Reclutamento
        • Geisinger Medical Oncology-Lewisburg
        • Investigatore principale:
          • Mina Makary
        • Contatto:
      • Mechanicsburg, Pennsylvania, Stati Uniti, 17050
        • Reclutamento
        • UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion
        • Contatto:
        • Investigatore principale:
          • Anwaar Saeed
      • Monroeville, Pennsylvania, Stati Uniti, 15146
        • Reclutamento
        • UPMC Hillman Cancer Center - Monroeville
        • Investigatore principale:
          • Anwaar Saeed
        • Contatto:
      • N. Huntingdon, Pennsylvania, Stati Uniti, 15642
        • Reclutamento
        • Arnold Palmer Cancer Center Medical Oncology Norwin
        • Investigatore principale:
          • Anwaar Saeed
        • Contatto:
      • New Castle, Pennsylvania, Stati Uniti, 16105
        • Reclutamento
        • UPMC Hillman Cancer Center - New Castle
        • Contatto:
        • Investigatore principale:
          • Anwaar Saeed
      • Philadelphia, Pennsylvania, Stati Uniti, 19107
        • Reclutamento
        • Thomas Jefferson University Hospital
        • Contatto:
        • Investigatore principale:
          • Daniel Lin
      • Philadelphia, Pennsylvania, Stati Uniti, 19114
        • Reclutamento
        • Jefferson Torresdale Hospital
        • Contatto:
        • Investigatore principale:
          • Daniel Lin
      • Pittsburgh, Pennsylvania, Stati Uniti, 15215
        • Reclutamento
        • UPMC-Saint Margaret
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 412-784-4900
        • Investigatore principale:
          • Anwaar Saeed
      • Pittsburgh, Pennsylvania, Stati Uniti, 15237
        • Reclutamento
        • UPMC-Passavant Hospital
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 412-367-6454
        • Investigatore principale:
          • Anwaar Saeed
      • Pittsburgh, Pennsylvania, Stati Uniti, 15243
        • Reclutamento
        • UPMC-Saint Clair Hospital Cancer Center
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 412-502-3920
        • Investigatore principale:
          • Anwaar Saeed
      • Pittsburgh, Pennsylvania, Stati Uniti, 15232
        • Reclutamento
        • UPMC Hillman Cancer Center
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 412-647-8073
        • Investigatore principale:
          • Anwaar Saeed
      • Scranton, Pennsylvania, Stati Uniti, 18510
        • Reclutamento
        • Community Medical Center
        • Investigatore principale:
          • Mina Makary
        • Contatto:
      • Seneca, Pennsylvania, Stati Uniti, 16346
        • Reclutamento
        • UPMC Cancer Center at UPMC Northwest
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 814-676-7900
        • Investigatore principale:
          • Anwaar Saeed
      • Uniontown, Pennsylvania, Stati Uniti, 15401
        • Reclutamento
        • UPMC Cancer Center-Uniontown
        • Contatto:
        • Investigatore principale:
          • Anwaar Saeed
      • Wilkes-Barre, Pennsylvania, Stati Uniti, 18711
        • Reclutamento
        • Geisinger Wyoming Valley/Henry Cancer Center
        • Contatto:
        • Investigatore principale:
          • Mina Makary
      • Willow Grove, Pennsylvania, Stati Uniti, 19090
        • Reclutamento
        • Asplundh Cancer Pavilion
        • Contatto:
        • Investigatore principale:
          • Daniel Lin
    • Rhode Island
      • Westerly, Rhode Island, Stati Uniti, 02891
        • Reclutamento
        • Smilow Cancer Hospital Care Center - Westerly
        • Contatto:
        • Investigatore principale:
          • Yifei Zhang
    • South Carolina
      • Charleston, South Carolina, Stati Uniti, 29425
        • Reclutamento
        • Medical University of South Carolina
        • Contatto:
        • Investigatore principale:
          • Toros Dincman
      • Charleston, South Carolina, Stati Uniti, 29401
        • Reclutamento
        • Ralph H Johnson VA Medical Center
        • Contatto:
        • Investigatore principale:
          • Oleksandra Lupak
    • South Dakota
      • Rapid City, South Dakota, Stati Uniti, 57701
        • Reclutamento
        • Rapid City Regional Hospital
        • Investigatore principale:
          • Abdel-Ghani Azzouqa
        • Contatto:
      • Sioux Falls, South Dakota, Stati Uniti, 57104
        • Reclutamento
        • Sanford Cancer Center Oncology Clinic
        • Investigatore principale:
          • Daniel Almquist
        • Contatto:
      • Sioux Falls, South Dakota, Stati Uniti, 57117-5134
        • Reclutamento
        • Sanford USD Medical Center - Sioux Falls
        • Investigatore principale:
          • Daniel Almquist
        • Contatto:
    • Tennessee
      • Knoxville, Tennessee, Stati Uniti, 37920
        • Reclutamento
        • University of Tennessee - Knoxville
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 865-544-9773
        • Investigatore principale:
          • Saikrishna Gadde
      • Nashville, Tennessee, Stati Uniti, 37232
        • Sospeso
        • Vanderbilt University/Ingram Cancer Center
    • Texas
      • Houston, Texas, Stati Uniti, 77030
        • Reclutamento
        • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 713-798-1354
          • Email: burton@bcm.edu
        • Investigatore principale:
          • Karen Riggins
      • Houston, Texas, Stati Uniti, 77030
        • Reclutamento
        • Ben Taub General Hospital
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 713-873-2000
        • Investigatore principale:
          • Karen Riggins
    • Utah
      • Farmington, Utah, Stati Uniti, 84025
        • Reclutamento
        • Farmington Health Center
        • Investigatore principale:
          • Christopher D. Nevala-Plagemann
        • Contatto:
      • Salt Lake City, Utah, Stati Uniti, 84106
        • Reclutamento
        • University of Utah Sugarhouse Health Center
        • Investigatore principale:
          • Christopher D. Nevala-Plagemann
        • Contatto:
      • Salt Lake City, Utah, Stati Uniti, 84112
        • Reclutamento
        • Huntsman Cancer Institute/University of Utah
        • Investigatore principale:
          • Christopher D. Nevala-Plagemann
        • Contatto:
    • Vermont
      • Berlin Corners, Vermont, Stati Uniti, 05602
        • Attivo, non reclutante
        • Central Vermont Medical Center/National Life Cancer Treatment
      • Burlington, Vermont, Stati Uniti, 05401
        • Attivo, non reclutante
        • University of Vermont Medical Center
      • Burlington, Vermont, Stati Uniti, 05405
        • Attivo, non reclutante
        • University of Vermont and State Agricultural College
    • Virginia
      • Richmond, Virginia, Stati Uniti, 23235
        • Reclutamento
        • VCU Massey Cancer Center at Stony Point
        • Investigatore principale:
          • Jennifer L. Myers
        • Contatto:
      • Richmond, Virginia, Stati Uniti, 23298
        • Reclutamento
        • VCU Massey Comprehensive Cancer Center
        • Investigatore principale:
          • Jennifer L. Myers
        • Contatto:
    • Wisconsin
      • Antigo, Wisconsin, Stati Uniti, 54409
        • Reclutamento
        • Aspirus Cancer Care-Antigo-Volm Cancer Center
        • Contatto:
        • Investigatore principale:
          • Andrew J. Huang
      • Ashland, Wisconsin, Stati Uniti, 54806
        • Reclutamento
        • Duluth Clinic Ashland
        • Contatto:
        • Investigatore principale:
          • Bret E. Friday
      • Burlington, Wisconsin, Stati Uniti, 53105
        • Reclutamento
        • Aurora Cancer Care-Southern Lakes VLCC
        • Contatto:
        • Investigatore principale:
          • Edward S. James
      • Cudahy, Wisconsin, Stati Uniti, 53110
        • Reclutamento
        • Aurora Saint Luke's South Shore
        • Contatto:
        • Investigatore principale:
          • Edward S. James
      • Eau Claire, Wisconsin, Stati Uniti, 54701
      • Germantown, Wisconsin, Stati Uniti, 53022
        • Reclutamento
        • Aurora Health Care Germantown Health Center
        • Contatto:
        • Investigatore principale:
          • Edward S. James
      • Grafton, Wisconsin, Stati Uniti, 53024
        • Reclutamento
        • Aurora Cancer Care-Grafton
        • Contatto:
        • Investigatore principale:
          • Edward S. James
      • Green Bay, Wisconsin, Stati Uniti, 54311
        • Reclutamento
        • Aurora BayCare Medical Center
        • Contatto:
        • Investigatore principale:
          • Edward S. James
      • Green Bay, Wisconsin, Stati Uniti, 54301
        • Reclutamento
        • Saint Vincent Hospital Cancer Center Green Bay
        • Investigatore principale:
          • Matthew L. Ryan
        • Contatto:
      • Green Bay, Wisconsin, Stati Uniti, 54303
        • Reclutamento
        • Saint Vincent Hospital Cancer Center at Saint Mary's
        • Investigatore principale:
          • Matthew L. Ryan
        • Contatto:
      • Kenosha, Wisconsin, Stati Uniti, 53142
        • Reclutamento
        • Aurora Cancer Care-Kenosha South
        • Contatto:
        • Investigatore principale:
          • Edward S. James
      • Madison, Wisconsin, Stati Uniti, 53705
        • Reclutamento
        • William S Middleton VA Medical Center
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 17007 608-256-1901
        • Investigatore principale:
          • Sam J. Lubner
      • Madison, Wisconsin, Stati Uniti, 53792
        • Reclutamento
        • University of Wisconsin Carbone Cancer Center - University Hospital
        • Investigatore principale:
          • Nataliya V. Uboha
        • Contatto:
      • Madison, Wisconsin, Stati Uniti, 53718
        • Reclutamento
        • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center
        • Investigatore principale:
          • Nataliya V. Uboha
        • Contatto:
      • Marinette, Wisconsin, Stati Uniti, 54143
        • Reclutamento
        • Aurora Bay Area Medical Group-Marinette
        • Contatto:
        • Investigatore principale:
          • Edward S. James
      • Marshfield, Wisconsin, Stati Uniti, 54449
      • Medford, Wisconsin, Stati Uniti, 54451
        • Reclutamento
        • Aspirus Medford Hospital
        • Investigatore principale:
          • Andrew J. Huang
        • Contatto:
      • Milwaukee, Wisconsin, Stati Uniti, 53209
        • Reclutamento
        • Aurora Cancer Care-Milwaukee
        • Contatto:
        • Investigatore principale:
          • Edward S. James
      • Milwaukee, Wisconsin, Stati Uniti, 53215
        • Reclutamento
        • Aurora Saint Luke's Medical Center
        • Contatto:
        • Investigatore principale:
          • Edward S. James
      • Milwaukee, Wisconsin, Stati Uniti, 53233
        • Reclutamento
        • Aurora Sinai Medical Center
        • Contatto:
        • Investigatore principale:
          • Edward S. James
      • Minocqua, Wisconsin, Stati Uniti, 54548
      • Mukwonago, Wisconsin, Stati Uniti, 53149
        • Reclutamento
        • ProHealth D N Greenwald Center
        • Contatto:
        • Investigatore principale:
          • Timothy R. Wassenaar
      • Oconomowoc, Wisconsin, Stati Uniti, 53066
        • Reclutamento
        • ProHealth Oconomowoc Memorial Hospital
        • Investigatore principale:
          • Timothy R. Wassenaar
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 262-928-7878
      • Oconto Falls, Wisconsin, Stati Uniti, 54154
        • Reclutamento
        • Saint Vincent Hospital Cancer Center at Oconto Falls
        • Investigatore principale:
          • Matthew L. Ryan
        • Contatto:
      • Oshkosh, Wisconsin, Stati Uniti, 54904
        • Reclutamento
        • Vince Lombardi Cancer Clinic - Oshkosh
        • Contatto:
        • Investigatore principale:
          • Edward S. James
      • Racine, Wisconsin, Stati Uniti, 53406
        • Reclutamento
        • Aurora Cancer Care-Racine
        • Contatto:
        • Investigatore principale:
          • Edward S. James
      • Rhinelander, Wisconsin, Stati Uniti, 54501
        • Reclutamento
        • Aspirus Cancer Care-Rhinelander-James Beck Cancer Center
        • Investigatore principale:
          • Andrew J. Huang
        • Contatto:
      • Rice Lake, Wisconsin, Stati Uniti, 54868
      • Sheboygan, Wisconsin, Stati Uniti, 53081
        • Reclutamento
        • Vince Lombardi Cancer Clinic-Sheboygan
        • Contatto:
        • Investigatore principale:
          • Edward S. James
      • Sheboygan, Wisconsin, Stati Uniti, 53081
        • Reclutamento
        • Saint Vincent Hospital Cancer Center at Sheboygan
        • Investigatore principale:
          • Matthew L. Ryan
        • Contatto:
      • Sheboygan, Wisconsin, Stati Uniti, 53081
        • Reclutamento
        • Sheboygan Physicians Group
        • Investigatore principale:
          • Matthew L. Ryan
        • Contatto:
      • Stevens Point, Wisconsin, Stati Uniti, 54482
      • Stevens Point, Wisconsin, Stati Uniti, 54481
        • Reclutamento
        • Aspirus Cancer Care - Stevens Point
        • Investigatore principale:
          • Andrew J. Huang
        • Contatto:
      • Sturgeon Bay, Wisconsin, Stati Uniti, 54235-1495
        • Reclutamento
        • Saint Vincent Hospital Cancer Center at Sturgeon Bay
        • Investigatore principale:
          • Matthew L. Ryan
        • Contatto:
      • Summit, Wisconsin, Stati Uniti, 53066
        • Reclutamento
        • Aurora Medical Center in Summit
        • Contatto:
        • Investigatore principale:
          • Edward S. James
      • Two Rivers, Wisconsin, Stati Uniti, 54241
        • Reclutamento
        • Vince Lombardi Cancer Clinic-Two Rivers
        • Contatto:
        • Investigatore principale:
          • Edward S. James
      • Waukesha, Wisconsin, Stati Uniti, 53188
        • Reclutamento
        • ProHealth Waukesha Memorial Hospital
        • Investigatore principale:
          • Timothy R. Wassenaar
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 262-928-7632
      • Waukesha, Wisconsin, Stati Uniti, 53188
        • Reclutamento
        • UW Cancer Center at ProHealth Care
        • Investigatore principale:
          • Timothy R. Wassenaar
        • Contatto:
      • Wausau, Wisconsin, Stati Uniti, 54401
        • Reclutamento
        • Aspirus Cancer Care-Wausau
        • Investigatore principale:
          • Andrew J. Huang
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 877-405-6866
      • Wauwatosa, Wisconsin, Stati Uniti, 53226
        • Reclutamento
        • Aurora Cancer Care-Milwaukee West
        • Contatto:
        • Investigatore principale:
          • Edward S. James
      • West Allis, Wisconsin, Stati Uniti, 53227
        • Reclutamento
        • Aurora West Allis Medical Center
        • Contatto:
        • Investigatore principale:
          • Edward S. James
      • Weston, Wisconsin, Stati Uniti, 54476
      • Wisconsin Rapids, Wisconsin, Stati Uniti, 54494
        • Reclutamento
        • Aspirus Cancer Care - Wisconsin Rapids
        • Investigatore principale:
          • Andrew J. Huang
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 715-422-7718

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

18 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • Participants must have advanced or locally unresectable gastric, gastroesophageal junction or esophageal adenocarcinoma

  • Participants must have PD-L1 CPS (Combined Positive Score) ≥ 1. This test would have been performed as part of standard of care (SOC) pathology testing, using tissue obtained within two years prior to registration and collected prior to or after a frontline regimen

  • Participants must have a histologically confirmed diagnosis of microsatellite stable (MSS) and HER2 negative gastric, gastroesophageal junction, or esophageal adenocarcinoma

  • Participants must have documented unresectable and/or metastatic disease on CT or MRI imaging completed prior to registration. Imaging must have been completed within 28 days prior to registration for participants with measurable disease. CT scans or MRIs used to assess non-measurable disease must have been completed within 42 days prior to registration. All disease must be assessed and documented on the Baseline Tumor Assessment Form

  • Participants with treated brain metastases must have no evidence of progression on the follow-up brain imaging after central nervous system (CNS)-directed therapy. All treatment for brain metastases must have been completed at least 28 days prior to registration

  • Participants must have disease progression or intolerance to frontline standard of care (SOC) chemotherapy plus either nivolumab, pembrolizumab or any other PD-1 or PD-L1 inhibitor. Peri-operative chemotherapy plus nivolumab, pembrolizumab or any other PD-1 or PD-L1 inhibitor will count as one line if disease progression occurs while on the therapy or within 6 months of completing the chemotherapy plus nivolumab or pembrolizumab or other PD-1/PD-L1 inhibitor cycle

  • Participants must not have received more than one prior line of systemic therapy defined as chemotherapy plus either nivolumab, pembrolizumab, or any other PD-1 or PD-L1 inhibitor, in the stage IV or unresectable setting. Peri-operative or adjuvant nivoluamb or other PD-1/PD-L1 inhibitors would count as one prior line of systemic therapy if patients progressed while on nivolumab (or other PD-1/PD-L1 inhibitors) or within 6 months of stopping it

    • Note: Radiation or any other regional therapy options done to address local residual disease or metastatic disease would not count as a line of therapy. Maintenance therapy with a different form of fluoropyrimidine (i.e. switching from capecitabine to fluorouracil [5FU]) would not count as another line of therapy

  • Participants must not have a condition requiring systemic treatment with either corticosteroids (> 10 mg daily prednisone equivalents) or other immunosuppressive medications within 14 days of registration. Inhaled or topical steroids and adrenal replacement doses < 10 mg daily prednisone equivalents are permitted in the absence of active autoimmune disease. Participants are permitted to use topical, ocular, intra-articular, intranasal, and inhalational corticosteroids (with minimal systemic absorption). Physiologic replacement doses of systemic corticosteroids are permitted, even if < 10 mg/day prednisone equivalents. A brief course of corticosteroids for prophylaxis (e.g., contrast dye allergy) or for treatment of non-autoimmune conditions (e.g., delayed-type hypersensitivity reaction caused by contact allergen) is permitted, as long as there has been a washout period for corticosteroids of ≥ 7 days prior to registration

  • Participants must not have prior significant immunotherapy related adverse events requiring permanent discontinuation of the immunotherapy agent including events like pneumonitis, myocarditis, renal failure, Guillain barre syndrome, or myasthenia gravis. Participants with endocrinopathy events leading or not to replacement steroids, thyroid hormone, insulin, or cortisol are eligible

  • Participants must not have received a live attenuated vaccination within 28 days prior to registration

  • Participants must not have had a major surgery within 28 days or subcutaneous venous access device placement within 7 days prior registration

  • Participants must have fully recovered from the effects of prior surgery in the opinion of the treating investigator. Any participants with postoperative bleeding complications or wound complications from a surgical procedure performed in the last eight weeks should be excluded

  • Participants must not have plans to undergo elective or planned major surgery during the clinical trial

  • Participants must not have active bleeding or prior history of gastrointestinal (GI) perforation, fistula or significant GI bleeding (requiring transfusion, endoscopic or surgical intervention) within 84 days prior to registration

  • Participants must not be planning to receive any concurrent chemotherapy, immunotherapy, investigational agents, biologic or hormonal therapy for cancer treatment while receiving treatment on this study

  • Participants must not have a history of a grade 3 or 4 allergic reaction attributed to humanized or human monoclonal antibody therapy

  • Participants must not have a history of grade 3 or 4 immunotherapy related toxicities with the exception of hormonal abnormalities like thyroiditis or thyroid derangements

  • Participants must be ≥ 18 years old

  • Participants must have Zubrod Performance Status of 0-2

  • Participants must have a complete medical history and physical exam within 28 days prior to registration

  • Leukocytes ≥ 2 x 10^3/uL (within 28 days prior to registration)

  • Absolute neutrophil count ≥ 1.2 x 10^3/uL (within 28 days prior to registration)

  • Hemoglobin ≥ 9.0 g/dL (within 28 days prior to registration)

  • Platelets ≥ 100 x 10^3/uL (within 28 days prior to registration)

  • Total bilirubin ≤ 1.5 x institutional upper limit of normal (ULN) (within 28 days prior to registration) unless history of Gilbert's disease. Participants with history of Gilbert's disease must have total bilirubin ≤ 5 x institutional ULN

  • Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) ≤ 3 × institutional ULN (within 28 days prior to registration) (unless liver metastases are present, in which case they must be ≤ 5 x ULN)

  • Participants must have a calculated creatinine clearance ≥ 40 mL/min using the following Cockcroft-Gault Formula. This specimen must have been drawn and processed within 28 days prior to registration

  • Participants' urinary protein must be ≤ 1+ on dipstick or routine urinalysis (UA) within 28 days of registration. Random analysis of urine protein with a normal value is sufficient. If urine dipstick or routine analysis indicated proteinuria ≥ 2+, then a 24-hour urine is to be collected and demonstrate < 1000 mg of protein in 24 hours to allow participation in the study

  • Participants must have adequate cardiac function. Participants with known history or current symptoms of cardiac disease, or history of treatment with cardiotoxic agents, must have a clinical risk assessment of cardiac function using the New York Heart Association Functional Classification. To be eligible for this trial, participants must be class 2 or better

  • Participants must have recovered to baseline or < grade 2 CTCAE version (v) 5.0 from toxicities related to any prior treatments, unless AE(s) are clinically stable on supportive therapy

  • Participants must not have experienced arterial thromboembolic events, including but not limited to myocardial infarction, transient ischemic attack, cerebrovascular accident, or unstable angina, within 6 months prior to registration

  • Participants must not have uncontrolled blood pressure within 28 days prior to registration as determined by the treating investigator

  • Participants with known human immunodeficiency virus (HIV)-infection must be on effective anti-retroviral therapy at registration and have undetectable viral load on the most recent test results obtained within 6 months prior to registration

  • Participants with evidence of chronic hepatitis B virus (HBV) infection must have undetectable HBV viral load while on suppressive therapy on the most recent test results obtained within 6 months prior to registration, if indicated

  • Participants with a history of hepatitis C virus (HCV) infection must have been treated and cured. Participants currently being treated for HCV infection must have undetectable HCV viral load on the most recent test results obtained within 6 months prior to registration, if indicated

  • Participants must not have a prior or concurrent malignancy whose natural history or treatment (in the opinion of the treating physician) has the potential to interfere with the safety or efficacy assessment of the investigational regimen

  • Participants must not be pregnant or nursing (nursing includes breast milk fed to an infant by any means, including from the breast, milk expressed by hand, or pumped). Individuals who are of reproductive potential must have agreed to use an effective contraceptive method with details provided as a part of the consent process. A person who has had menses at any time in the preceding 12 consecutive months or who has semen likely to contain sperm is considered to be of "reproductive potential." In addition to routine contraceptive methods, "effective contraception" also includes refraining from sexual activity that might result in pregnancy and surgery intended to prevent pregnancy (or with a side-effect of pregnancy prevention) including hysterectomy, bilateral oophorectomy, bilateral tubal ligation/occlusion, and vasectomy with testing showing no sperm in the semen

  • Participants must not have a history of inflammatory bowel disease, (including ulcerative colitis and Crohn's disease), symptomatic autoimmune disease (e.g., rheumatoid arthritis, systemic progressive sclerosis [scleroderma], systemic lupus erythematosus, autoimmune vasculitis [e.g., Wegener's Granulomatosis]); CNS or motor neuropathy considered of autoimmune origin (e.g., Guillain-Barre Syndrome and myasthenia gravis, multiple sclerosis). Note: Participants with Graves' disease will be allowed

  • Participants must not have a history of pneumonitis that has required oral or IV steroids within the last 12 months prior to registration

  • Participants must be offered the opportunity to participate in specimen banking. With participant consent, specimens must be collected and submitted via the Southwest Oncology Group (SWOG) Specimen Tracking System

  • Participants who can complete patient reported outcomes (FACT-Ga and PRO-CTCAE) questionnaires in English or Spanish must participate in the quality of life studies

  • Participants must be informed of the investigational nature of this study and must sign and give informed consent in accordance with institutional and federal guidelines. For participants with impaired decision-making capabilities, legally authorized representatives may sign and give informed consent on behalf of study participants in accordance with applicable federal, local, and Central Institutional Review Board (CIRB) regulations

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Arm 1 (nivolumab, ramucirumab, paclitaxel)

Patients receive nivolumab IV over 30 minutes on day 1 of each cycle, ramucirumab IV over 30-60 minutes on days 1 and 15 of each cycle, and paclitaxel IV over 60 minutes on days 1, 8 and 15 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients undergo CT scan and MRI throughout the study. Patients may also optionally undergo blood sample collection on study.
Droga: Paclitaxel

Given IV

Altri nomi:
  • Tassolo
  • Anzatax
  • Asotax
  • Bristaxolo
  • Praxel
  • Taxol Konzentrat
Procedura: Magnetic Resonance Imaging

Undergo MRI

Altri nomi:
  • Risonanza magnetica
  • Scansione di immagini a risonanza magnetica
  • Imaging medico, risonanza magnetica/risonanza magnetica nucleare
  • SIG
  • Imaging RM
  • Scansione MRI
  • Imaging NMR
  • RMN
  • Risonanza Magnetica Nucleare
  • Imaging a risonanza magnetica (MRI)
  • sMRI
  • Imaging a risonanza magnetica (procedura)
  • RM strutturale
Altro: Questionnaire Administration

Ancillary studies

Biologico: Nivolumab

Given IV

Altri nomi:
  • BMS-936558
  • MDX-1106
  • NIVO
  • ONO-4538
  • Opdivo
  • CMAB819
  • Nivolumab biosimilare CMAB819
  • MDX 1106
  • MDX1106
  • BMS 936558
  • ABP 206
  • Nivolumab biosimilare ABP 206
  • BCD-263
  • Nivolumab biosimilare BCD-263
  • BMS936558
  • ONO4538
Procedura: Computed Tomography

Undergo CT scan

Altri nomi:
  • CT
  • GATTO
  • TAC
  • Tomografia assiale computerizzata
  • Tomografia computerizzata
  • tomografia
  • Tomografia assiale computerizzata (procedura)
  • Scansione tomografia computerizzata (CT).
  • Scansione CAT diagnostica
  • Tipo di servizio di scansione CAT diagnostica
Biologico: Ramucirumab

Given IV

Altri nomi:
  • LY3009806
  • LY 3009806
  • IMC-1121B
  • Cyramza
  • Anticorpo monoclonale completamente umano Anti-VEGFR-2 IMC-1121B
  • Anticorpo monoclonale HGS-ETR2
  • IMC 1121B
  • IMC1121B
  • LY-3009806
Procedura: Biospecimen Collection

Undergo optional blood sample collection

Altri nomi:
  • Raccolta di campioni biologici
  • Biocampione raccolto
  • Raccolta di campioni
  • Raccolta campione
Comparatore attivo: Arm 2 (ramucirumab, paclitaxel)

Patients receive ramucirumab IV over 30-60 minutes on days 1 and 15 of each cycle and paclitaxel IV over 60 minutes on days 1, 8 and 15 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients undergo CT scan and MRI throughout the study. Patients may also optionally undergo blood sample collection on study.
Droga: Paclitaxel

Given IV

Altri nomi:
  • Tassolo
  • Anzatax
  • Asotax
  • Bristaxolo
  • Praxel
  • Taxol Konzentrat
Procedura: Magnetic Resonance Imaging

Undergo MRI

Altri nomi:
  • Risonanza magnetica
  • Scansione di immagini a risonanza magnetica
  • Imaging medico, risonanza magnetica/risonanza magnetica nucleare
  • SIG
  • Imaging RM
  • Scansione MRI
  • Imaging NMR
  • RMN
  • Risonanza Magnetica Nucleare
  • Imaging a risonanza magnetica (MRI)
  • sMRI
  • Imaging a risonanza magnetica (procedura)
  • RM strutturale
Altro: Questionnaire Administration

Ancillary studies

Procedura: Computed Tomography

Undergo CT scan

Altri nomi:
  • CT
  • GATTO
  • TAC
  • Tomografia assiale computerizzata
  • Tomografia computerizzata
  • tomografia
  • Tomografia assiale computerizzata (procedura)
  • Scansione tomografia computerizzata (CT).
  • Scansione CAT diagnostica
  • Tipo di servizio di scansione CAT diagnostica
Biologico: Ramucirumab

Given IV

Altri nomi:
  • LY3009806
  • LY 3009806
  • IMC-1121B
  • Cyramza
  • Anticorpo monoclonale completamente umano Anti-VEGFR-2 IMC-1121B
  • Anticorpo monoclonale HGS-ETR2
  • IMC 1121B
  • IMC1121B
  • LY-3009806
Procedura: Biospecimen Collection

Undergo optional blood sample collection

Altri nomi:
  • Raccolta di campioni biologici
  • Biocampione raccolto
  • Raccolta di campioni
  • Raccolta campione

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Progression free survival (PFS) (Phase II)
Lasso di tempo: From date of randomization to date of first documentation of progression or symptomatic deterioration or death due to any cause, assessed up to 3 years

The distribution of PFS will be estimated using the method of Kaplan-Meier and compared using a 1-sided stratified log-rank test.
From date of randomization to date of first documentation of progression or symptomatic deterioration or death due to any cause, assessed up to 3 years
Overall survival (OS) (Phase III)
Lasso di tempo: From date of randomization to date of death due to any cause, assessed up to 3 years

The distribution of OS will be estimated using the method of Kaplan-Meier and compared using a 1-sided stratified log-rank test.
From date of randomization to date of death due to any cause, assessed up to 3 years

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Incidenza di eventi avversi
Lasso di tempo: Fino a 3 anni
Fino a 3 anni
Objective response rate (ORR)
Lasso di tempo: Up to 3 years

Will be compared across arms in participants with measurable disease via Fisher's exact test.
Up to 3 years
Disease control rate (DCR)
Lasso di tempo: Up to 3 years

DCR = ORR + stable disease per Response Evaluation Criteria in Solid Tumors 1.1. Will be compared across arms in participants with measurable disease via Fisher's exact test.
Up to 3 years

Altre misure di risultato

Misura del risultato
Misura Descrizione
Lasso di tempo
Disease-free survival (DFS)
Lasso di tempo: Up to 3 years

The hazard ratio of DFS and the corresponding 95% confidence intervals will be estimated for subgroups defined by sex, race, and ethnicity, respectively.
Up to 3 years

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

National Cancer Institute (NCI)

Investigatori

  • Investigatore principale: Anwaar Saeed, SWOG Cancer Research Network

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Pubblicazioni generali

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

24 giugno 2024

Completamento primario (Stimato)

31 ottobre 2027

Completamento dello studio (Stimato)

31 ottobre 2027

Date di iscrizione allo studio

Primo inviato

10 gennaio 2024

Primo inviato che soddisfa i criteri di controllo qualità

10 gennaio 2024

Primo Inserito (Effettivo)

12 gennaio 2024

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

30 ottobre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

29 ottobre 2026

Ultimo verificato

1 agosto 2026

Maggiori informazioni

Termini relativi a questo studio

Termini MeSH pertinenti aggiuntivi

Altri numeri di identificazione dello studio

  • NCI-2023-11064
  • U10CA180888 (Sovvenzione/contratto NIH degli Stati Uniti)
  • NCI-2023-11064 (Identificatore di registro: CTRP (Clinical Trial Reporting Program))
  • S2303 (Altro identificatore: CTEP)
  • S2303 (Altro identificatore: SWOG)

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

SÌ

Descrizione del piano IPD

"NCI is committed to sharing data in accordance with NIH policy. For more details on how clinical trial data is shared, access the link to the NIH data sharing policy page."

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

Sì

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

prodotto fabbricato ed esportato dagli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi